| Cognitive decline in preclinical Alzheimer’s disease: amyloid-beta versus tauopathy CM Huber, C Yee, T May, A Dhanala, CS Mitchell Journal of Alzheimer’s disease 61 (1), 265-281, 2017 | 140 | 2017 |
| Systematic review of the relationship between amyloid-β levels and measures of transgenic mouse cognitive deficit in Alzheimer's disease AM Foley, ZM Ammar, RH Lee, CS Mitchell Journal of Alzheimer's Disease 44 (3), 787-795, 2015 | 111 | 2015 |
| Characterization of the contribution of genetic background and gender to disease progression in the SOD1 G93A mouse model of amyotrophic lateral sclerosis: a meta-analysis SR Pfohl, MT Halicek, CS Mitchell Journal of neuromuscular diseases 2 (2), 137-150, 2015 | 107 | 2015 |
| Denoising multi-source weak supervision for neural text classification W Ren, Y Li, H Su, D Kartchner, C Mitchell, C Zhang arXiv preprint arXiv:2010.04582, 2020 | 73 | 2020 |
| An assessment of possible neuropathology and clinical relationships in 46 sporadic amyotrophic lateral sclerosis patient autopsies G Coan, CS Mitchell Neurodegenerative Diseases 15 (5), 301-312, 2015 | 64 | 2015 |
| Antecedent disease and amyotrophic lateral sclerosis: what is protecting whom? SK Hollinger, IS Okosun, CS Mitchell Frontiers in neurology 7, 47, 2016 | 57 | 2016 |
| A metadata analysis of oxidative stress etiology in preclinical amyotrophic lateral sclerosis: benefits of antioxidant therapy L Bond, K Bernhardt, P Madria, K Sorrentino, H Scelsi, CS Mitchell Frontiers in Neuroscience 12, 10, 2018 | 54 | 2018 |
| Associative increases in amyotrophic lateral sclerosis survival duration with non-invasive ventilation initiation and usage protocols N Khamankar, G Coan, B Weaver, CS Mitchell Frontiers in neurology 9, 578, 2018 | 49 | 2018 |
| A comprehensive examination of percutaneous endoscopic gastrostomy and its association with amyotrophic lateral sclerosis patient outcomes L Bond, P Ganguly, N Khamankar, N Mallet, G Bowen, B Green, ... Brain Sciences 9 (9), 223, 2019 | 48 | 2019 |
| Antecedent disease is less prevalent in amyotrophic lateral sclerosis CS Mitchell, SK Hollinger, SD Goswami, MA Polak, RH Lee, JD Glass Neurodegenerative Diseases 15 (2), 109-113, 2015 | 48 | 2015 |
| Unraveling the complexity of amyotrophic lateral sclerosis survival prediction SR Pfohl, RB Kim, GS Coan, CS Mitchell Frontiers in neuroinformatics 12, 36, 2018 | 46 | 2018 |
| Seeking homeostasis: temporal trends in respiration, oxidation, and calcium in SOD1 G93A Amyotrophic Lateral Sclerosis mice CW Irvin, RB Kim, CS Mitchell Frontiers in cellular neuroscience 9, 248, 2015 | 37 | 2015 |
| State of the field: An informatics-based systematic review of the SOD1-G93A amyotrophic lateral sclerosis transgenic mouse model RB Kim, CW Irvin, KR Tilva, CS Mitchell Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 17 (1-2), 1-14, 2016 | 35 | 2016 |
| Monitoring protocols for cochlear toxicity SG Lord Seminars in hearing 40 (02), 122-143, 2019 | 33 | 2019 |
| Undergraduate biocuration: developing tomorrow’s researchers while mining today’s data CS Mitchell, A Cates, RB Kim, SK Hollinger Journal of Undergraduate Neuroscience Education 14 (1), A56, 2015 | 33 | 2015 |
| Type I vs. type II cytokine levels as a function of SOD1 G93A mouse amyotrophic lateral sclerosis disease progression A Jeyachandran, B Mertens, EA McKissick, CS Mitchell Frontiers in Cellular Neuroscience 9, 462, 2015 | 32 | 2015 |
| Biomedical text link prediction for drug discovery: a case study with COVID-19 K McCoy, S Gudapati, L He, E Horlander, D Kartchner, S Kulkarni, ... Pharmaceutics 13 (6), 794, 2021 | 29 | 2021 |
| Axonal transport cargo motor count versus average transport velocity: is fast versus slow transport really single versus multiple motor transport? RH Lee, CS Mitchell Journal of Theoretical Biology 370, 39-44, 2015 | 25 | 2015 |
| Zero-Shot Information Extraction for Clinical Meta-Analysis using Large Language Models D Kartchner, S Ramalingam, I Al-Hussaini, O Kronick, C Mitchell Association for Computational Linguistics, 2023 | 24 | 2023 |
| Associations of patient mood, modulators of quality of life, and pharmaceuticals with amyotrophic lateral sclerosis survival duration L Bond, G Bowen, B Mertens, K Denson, K Jordan, B Vidakovic, ... Behavioral Sciences 10 (1), 33, 2020 | 24 | 2020 |
